相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Perspectives on Geoff Burnstock as researcher, teacher and friend
Maria P. Abbracchio
BIOCHEMICAL PHARMACOLOGY (2021)
Macrophagic and microglial complexity after neuronal injury
Francina Mesquida-Veny et al.
PROGRESS IN NEUROBIOLOGY (2021)
Phytochemicals as regulators of microglia/macrophages activation in cerebral ischemia
Lalita Subedi et al.
PHARMACOLOGICAL RESEARCH (2021)
Geoffrey Burnstock (1929-2020): the finest pharmacologist and an inspiring scientist
Rafael Franco
PURINERGIC SIGNALLING (2021)
Microglial Polarization: Novel Therapeutic Strategy against Ischemic Stroke
Yimeng Xue et al.
AGING AND DISEASE (2021)
Transplantation of M2-Deviated Microglia Promotes Recovery of Motor Function after Spinal Cord Injury in Mice
Shuhei Kobashi et al.
MOLECULAR THERAPY (2020)
EXTRACELLULAR NUCLEOTIDES AND P2 RECEPTORS IN RENAL FUNCTION
Volker Vallon et al.
PHYSIOLOGICAL REVIEWS (2020)
Adenosine 2A Receptor Blockade as an Immunotherapy for Treatment-Refractory Renal Cell Cancer
Lawrence Fong et al.
CANCER DISCOVERY (2020)
A(2A) and A(2B) adenosine receptors: The extracellular loop 2 determines high (A(2A)) or low affinity (A(2B)) for adenosine
Elisabetta De Filippo et al.
BIOCHEMICAL PHARMACOLOGY (2020)
Microglia, Lifestyle Stress, and Neurodegeneration
Charlotte Madore et al.
IMMUNITY (2020)
Alternatively activated macrophages; a double-edged sword in allergic asthma
Mohamed Hamed Abdelaziz et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2020)
Lessons from the A2A Adenosine Receptor Antagonist-Enabled Tumor Regression and Survival in Patients with Treatment-Refractory Renal Cell Cancer
Michail V. Sitkovsky
CANCER DISCOVERY (2020)
Adenosine A2A Receptor Antagonists Affects NMDA Glutamate Receptor Function. Potential to Address Neurodegeneration in Alzheimer's Disease
Rafael Franco et al.
CELLS (2020)
P2 Purinergic Signaling in the Distal Lung in Health and Disease
Eva Wirsching et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Adenosine Receptors as Neuroinflammation Modulators: Role of A1Agonists and A2AAntagonists
Aleix Marti Navia et al.
CELLS (2020)
Obituary Geoff Burnstock (1929-2020)
Carsten Hoffmann et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2020)
Targeting the A2AR in cancer; early lessons from the clinic
Stephen B. Willingham et al.
CURRENT OPINION IN PHARMACOLOGY (2020)
Remote ischemic preconditioning-induced neuroprotection in cerebral ischemia-reperfusion injury: Preclinical evidence and mechanisms
Diwakar Sharma et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2020)
Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes
Hyuk Sung Kwon et al.
TRANSLATIONAL NEURODEGENERATION (2020)
The role and pharmacological characteristics of ATP-gated ionotropic receptor P2X in cancer pain
Wen-jun Zhang et al.
PHARMACOLOGICAL RESEARCH (2020)
A Glimmer of Hope: Maintain Mitochondrial Homeostasis to Mitigate Alzheimer's Disease
Wenbo Li et al.
AGING AND DISEASE (2020)
The biomedical challenge of neurodegenerative disorders: an opportunity for cannabinoid-based therapies to improve on the poor current therapeutic outcomes
Javier Fernandez-Ruiz
BRITISH JOURNAL OF PHARMACOLOGY (2019)
The role of adenosine in up-regulation of p38 MAPK and ERK during limb ischemic preconditioning-induced brain ischemic tolerance
Qiang Yuan et al.
BRAIN RESEARCH (2019)
Macrophages: versatile players in renal inflammation and fibrosis
Patrick Ming-Kuen Tang et al.
NATURE REVIEWS NEPHROLOGY (2019)
Potentiation of cannabinoid signaling in microglia by adenosine A2A receptor antagonists
Rafael Franco et al.
GLIA (2019)
THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: G protein-coupled receptors
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
The Ying and Yang of Adenosine A1 and A2A Receptors on ERK1/2 Activation in a Rat Model of Global Cerebral Ischemia Reperfusion Injury
Reham M. Atef et al.
MOLECULAR NEUROBIOLOGY (2018)
Cross-communication between Gi and Gs in a G-protein-coupled receptor heterotetramer guided by a receptor C-terminal domain
Gemma Navarro et al.
BMC BIOLOGY (2018)
Receptor-heteromer mediated regulation of endocannabinoid signaling in activated microglia. Role of CB1 and CB2 receptors and relevance for Alzheimer's disease and levodopa-induced dyskinesia
Gemma Navarro et al.
BRAIN BEHAVIOR AND IMMUNITY (2018)
Adenosine A2A receptor ligand recognition and signaling is blocked by A2B receptors
Sonja Hinz et al.
Oncotarget (2018)
Understanding the Role of Adenosine A2AR Heteroreceptor Complexes in Neurodegeneration and Neuroinflammation
Dasiel O. Borroto-Escuela et al.
FRONTIERS IN NEUROSCIENCE (2018)
Adenosine A2A Receptor Antagonists in Neurodegenerative Diseases: Huge Potential and Huge Challenges
Rafael Franco et al.
FRONTIERS IN PSYCHIATRY (2018)
The identity and function of microglia in neurodegeneration
Wilbur M. Song et al.
NATURE IMMUNOLOGY (2018)
Microglia in neurodegeneration
Suzanne Hickman et al.
NATURE NEUROSCIENCE (2018)
Epidemiology of Parkinson's Disease-East Versus West
Masoom M. Abbas et al.
MOVEMENT DISORDERS CLINICAL PRACTICE (2018)
Macrophages: friend or foe in idiopathic pulmonary fibrosis?
Lei Zhang et al.
RESPIRATORY RESEARCH (2018)
Adenosine A2A Receptors Modulate α-Synuclein Aggregation and Toxicity
Diana G. Ferreira et al.
CEREBRAL CORTEX (2017)
Astroglia as a cellular target for neuroprotection and treatment of neuro-psychiatric disorders
Beihui Liu et al.
GLIA (2017)
Old Maids: Aging and Its Impact on Microglia Function
Edward C. Koellhoffer et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Health benefits of methylxanthines in neurodegenerative diseases
Ainhoa Onatibia-Astibia et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2017)
A2B adenosine receptors stimulate IL-6 production in primary murine microglia through p38 MAPK kinase pathway
Stefania Merighi et al.
PHARMACOLOGICAL RESEARCH (2017)
Potential of GPCRs to modulate MAPK and mTOR pathways in Alzheimer's disease
Rafael Franco et al.
PROGRESS IN NEUROBIOLOGY (2017)
Treatment with A2A receptor antagonist KW6002 and caffeine intake regulate microglia reactivity and protect retina against transient ischemic damage
Raquel Boia et al.
CELL DEATH & DISEASE (2017)
Molecular Mechanisms Modulating the Phenotype of Macrophages and Microglia
Stephanie A. Amici et al.
FRONTIERS IN IMMUNOLOGY (2017)
THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: G protein-coupled receptors
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
Ischemic preconditioning with a ketogenic diet improves brain ischemic tolerance through increased extracellular adenosine levels and hypoxia-inducible factors
Qi Yang et al.
BRAIN RESEARCH (2017)
Neuroprotective Effect of JZL184 in MPP+-Treated SH-SY5Y Cells Through CB2 Receptors
Maria S. Aymerich et al.
MOLECULAR NEUROBIOLOGY (2016)
Quaternary structure of a G-protein-coupled receptor heterotetramer in complex with Gi and Gs
Gemma Navarro et al.
BMC BIOLOGY (2016)
A2A adenosine receptor antagonists to weaken the hypoxia-HIF-1α driven immunosuppression and improve immunotherapies of cancer
Stephen M. Hatfield et al.
CURRENT OPINION IN PHARMACOLOGY (2016)
How does adenosine control neuronal dysfunction and neurodegeneration?
Rodrigo A. Cunha
JOURNAL OF NEUROCHEMISTRY (2016)
The epidemiology of Parkinson's disease: risk factors and prevention
Alberto Ascherio et al.
LANCET NEUROLOGY (2016)
A polarizing question: do M1 and M2 microglia exist?
Richard M. Ransohoff
NATURE NEUROSCIENCE (2016)
Purinergic signalling in brain ischemia
Felicita Pedata et al.
NEUROPHARMACOLOGY (2016)
The potential of methylxanthine-based therapies in pediatric respiratory tract diseases
Ainhoa Onatibia-Astibia et al.
RESPIRATORY MEDICINE (2016)
Selective A2A receptor antagonist prevents microglia-mediated neuroinflammation and protects retinal ganglion cells from high intraocular pressure-induced transient ischemic injury
Maria H. Madeira et al.
TRANSLATIONAL RESEARCH (2016)
Mitochondrial angiotensin receptors in dopaminergic neurons. Role in cell protection and aging-related vulnerability to neurodegeneration
Rita Valenzuela et al.
CELL DEATH & DISEASE (2016)
Targeting Cannabinoid CB2 Receptors in the Central Nervous System. Medicinal Chemistry Approaches with Focus on Neurodegenerative Disorders
Gemma Navarro et al.
FRONTIERS IN NEUROSCIENCE (2016)
A Long-Term Study of Istradefylline Safety and Efficacy in Patients With Parkinson Disease
Tomoyoshi Kondo et al.
CLINICAL NEUROPHARMACOLOGY (2015)
Alternatively activated microglia and macrophages in the central nervous system
Rafael Franco et al.
PROGRESS IN NEUROBIOLOGY (2015)
Selectivity is species-dependent: Characterization of standard agonists and antagonists at human, rat, and mouse adenosine receptors
Mohamad Wessam Alnouri et al.
PURINERGIC SIGNALLING (2015)
Transferred inter-cell ischemic preconditioning-induced neuroprotection may be mediated by adenosine A1 receptors
Jungyeon Yun et al.
BRAIN RESEARCH BULLETIN (2014)
L-DOPA disrupts adenosine A2A-cannabinoid CB1-dopamine D2 receptor heteromer cross-talk in the striatum of hemiparkinsonian rats: Biochemical and behavioral studies
Annalisa Pinna et al.
EXPERIMENTAL NEUROLOGY (2014)
Purinergic signalling: from discovery to current developments
Geoffrey Burnstock
EXPERIMENTAL PHYSIOLOGY (2014)
Dose-response meta-analysis on coffee, tea and caffeine consumption with risk of Parkinson's disease
Hui Qi et al.
GERIATRICS & GERONTOLOGY INTERNATIONAL (2014)
Microglial VPAC1R Mediates a Novel Mechanism of Neuroimmune-Modulation of Hippocampal Precursor Cells Via IL-4 Release
Robert Nunan et al.
GLIA (2014)
Adenosine A2A Receptors Modulate Acute Injury and Neuroinflammation in Brain Ischemia
Felicita Pedata et al.
MEDIATORS OF INFLAMMATION (2014)
Role of Microglia Adenosine A(2A) Receptors in Retinal and Brain Neurodegenerative Diseases
Ana R. Santiago et al.
MEDIATORS OF INFLAMMATION (2014)
BAY60-6583 Acts as a Partial Agonist at Adenosine A2B Receptors
Sonja Hinz et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2014)
Caffeine Consumption Prevents Memory Impairment, Neuronal Damage, and Adenosine A2A Receptors Upregulation in the Hippocampus of a Rat Model of Sporadic Dementia
Janaina Espinosa et al.
JOURNAL OF ALZHEIMERS DISEASE (2013)
Activation of microglial cells triggers a release of brain-derived neurotrophic factor (BDNF) inducing their proliferation in an adenosine A2A receptor-dependent manner: A2A receptor blockade prevents BDNF release and proliferation of microglia
Catarina Gomes et al.
JOURNAL OF NEUROINFLAMMATION (2013)
Adenosine A2A receptor antagonist istradefylline reduces daily OFF time in Parkinson's disease
Yoshikuni Mizuno et al.
MOVEMENT DISORDERS (2013)
Microglia during development and aging
G. Jean Harry
PHARMACOLOGY & THERAPEUTICS (2013)
A1R-A2AR heteromers coupled to Gs and Gi/0 proteins modulate GABA transport into astrocytes
Sofia Cristovao-Ferreira et al.
PURINERGIC SIGNALLING (2013)
Health Benefits of Methylxanthines in Cacao and Chocolate
Rafael Franco et al.
NUTRIENTS (2013)
Caffeine Intake, Smoking, and Risk of Parkinson Disease in Men and Women
Rui Liu et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2012)
Activation of microglial N-methyl-D-aspartate receptors triggers inflammation and neuronal cell death in the developing and mature brain
Angela M. Kaindl et al.
ANNALS OF NEUROLOGY (2012)
The birth of oligodendrocytes in the anatomical and neuropathological literature: the seminal contribution of Pio del Rio-Hortega
Hans Lassmann
CLINICAL NEUROPATHOLOGY (2012)
Mitochondrial CB1 receptors regulate neuronal energy metabolism
Giovanni Benard et al.
NATURE NEUROSCIENCE (2012)
Microglial activation in healthy aging
Alie Schuitemaker et al.
NEUROBIOLOGY OF AGING (2012)
Environmental risk factors for REM sleep behavior disorder A multicenter case-control study
R. B. Postuma et al.
NEUROLOGY (2012)
Macrophage polarization and bacterial infections
Jean-Louis Mege et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2011)
Abnormal calcium handling in atrial fibrillation is linked to up-regulation of adenosine A2A receptors
Anna Llach et al.
EUROPEAN HEART JOURNAL (2011)
Role of microglia in CNS inflammation
Manuel B. Graeber et al.
FEBS LETTERS (2011)
Adenosine A2A receptors control neuroinflammation and consequent hippocampal neuronal dysfunction
Nelson Rebola et al.
JOURNAL OF NEUROCHEMISTRY (2011)
Past, present and future of A2A adenosine receptor antagonists in the therapy of Parkinson's disease
Marie Therese Armentero et al.
PHARMACOLOGY & THERAPEUTICS (2011)
Adenosine 2A receptor: a crucial neuromodulator with bidirectional effect in neuroinflammation and brain injury
Shuang-Shuang Dai et al.
REVIEWS IN THE NEUROSCIENCES (2011)
Midlife Healthy-Diet Index and Late-Life Dementia and Alzheimer's Disease
Marjo H. Eskelinen et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS EXTRA (2011)
The endocannabinoid system as a target for the treatment of neurodegenerative disease
Emma L. Scotter et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Caffeine as a Protective Factor in Dementia and Alzheimer's Disease
Marjo H. Eskelinen et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
Caffeine and Adenosine
Joaquim A. Ribeiro et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
Cooperative Cardioprotection Through Adenosine A1 and A2A Receptor Agonism in Ischemia-Reperfused Isolated Mouse Heart
Vijay B. Urmaliya et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2010)
Caffeine and CSC, adenosine A(2A) antagonists, offer neuroprotection against 6-OHDA-induced neurotoxicity in rat mesencephalic cells
Helio Vitoriano Nobre et al.
NEUROCHEMISTRY INTERNATIONAL (2010)
Changing Face of Microglia
Manuel B. Graeber
SCIENCE (2010)
Unconventional neurotransmitters, neurodegeneration and neuroprotection
M. Leonelli et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2009)
Midlife Coffee and Tea Drinking and the Risk of Late-Life Dementia: A Population-Based CAIDE Study
Marjo H. Eskelinen et al.
JOURNAL OF ALZHEIMERS DISEASE (2009)
Adenosine A2A Receptor Blockade Prevents Synaptotoxicity and Memory Dysfunction Caused by β-Amyloid Peptides via p38 Mitogen-Activated Protein Kinase Pathway
Paula M. Canas et al.
JOURNAL OF NEUROSCIENCE (2009)
Building a new conceptual framework for receptor heteromers
Sergi Ferre et al.
NATURE CHEMICAL BIOLOGY (2009)
Differential regulation of microglial motility by ATP/ADP and adenosine
Stefka Gyoneva et al.
PARKINSONISM & RELATED DISORDERS (2009)
Vasoactive intestinal peptide inhibits cycloxygenase-2 expression in activated macrophages, microglia, and dendritic cells
Elena Gonzalez-Rey et al.
BRAIN BEHAVIOR AND IMMUNITY (2008)
Caffeine, adenosine receptors, memory and Alzheimer disease
Rodrigo A. Cunha
MEDICINA CLINICA (2008)
Adenosine A2A receptors and brain injury:: Broad spectrum of neuroprotection, multifaceted actions and fine tuning modulation
Jiang-Fan Chen et al.
PROGRESS IN NEUROBIOLOGY (2007)
Striatal adenosine A2A and Cannabinoid CB1 receptors form functional heteromeric complexes that mediate the motor effects of Cannabinoids
Paulina Carriba et al.
NEUROPSYCHOPHARMACOLOGY (2007)
Microglial activation in presymptomatic Huntington's disease gene carriers
Yen F. Tai et al.
BRAIN (2007)
Effects of the adenosine A2A receptor antagonist SCH 58621 on cyclooxygenase-2 expression, glial activation, and brain-derived neurotrophic factor availability in a rat model of striatal neurodegeneration
Luisa Minghetti et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2007)
Microglial control of neuronal death and synaptic properties
Alain Bessis et al.
GLIA (2007)
Reply: Does the adenosine A(2A) receptor stimulate the ryanodine receptor?
Leif Hove-Madsen et al.
CARDIOVASCULAR RESEARCH (2007)
Physiology and pathophysiology of purinergic neurotransmission
Geoffrey Burnstock
PHYSIOLOGICAL REVIEWS (2007)
Adenosine A2A receptors are expressed in human atrial myocytes and modulate spontaneous sarcoplasmic reticulum calcium release
Leif Hove-Madsen et al.
CARDIOVASCULAR RESEARCH (2006)
Microglial activation correlates with severity in Huntington disease - A clinical and PET study
N. Pavese et al.
NEUROLOGY (2006)
Microglia in the aging brain
Jessica R. Conde et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2006)
Presynaptic control of striatal glutamatergic neurotransmission by adenosine A1-A2A receptor heteromers
F Ciruela et al.
JOURNAL OF NEUROSCIENCE (2006)
Adenosine A2A receptor stimulation potentiates nitric oxide release by activated microglia
J Saura et al.
JOURNAL OF NEUROCHEMISTRY (2005)
Adenosine receptor signaling in the brain immune system
G Haskó et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2005)
Adenosine A(2A) and dopamine D-2 heteromeric receptor complexes and their function
K Fuxe et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2005)
A short cerebral ischemic preconditioning up-regulates adenosine receptors in the hippocampal CA1 region of rats
AM Zhou et al.
NEUROSCIENCE RESEARCH (2004)
Endogenous neuroprotection in the retina
S Roth
BRAIN RESEARCH BULLETIN (2004)
Neuroprotective effect of L-DOPA co-administered with the adenosine A2A receptor agonist CGS 21680 in an animal model of Parkinson's disease
LF Agnati et al.
BRAIN RESEARCH BULLETIN (2004)
Striatal plasticity at the network level.: Focus on adenosine A2A and D2 interactions in models of Parkinson's Disease
S Tanganelli et al.
PARKINSONISM & RELATED DISORDERS (2004)
Adenosine A2A-dopamine D2 receptor-receptor heteromers.: Targets for neuro-psychiatric disorders
S Ferré et al.
PARKINSONISM & RELATED DISORDERS (2004)
Brief, repeated, oxygen-glucose deprivation episodes protect neurotransmission from a longer ischemic episode in the in vitro hippocampus:: role of adenosine receptors
AM Pugliese et al.
BRITISH JOURNAL OF PHARMACOLOGY (2003)
Evidence for functional adenosine A3 receptors in microglia cells
C Hammarberg et al.
JOURNAL OF NEUROCHEMISTRY (2003)
Inhibition of interferon (IFN) γ-induced Jak-STAT1 activation in microglia by vasoactive intestinal peptide -: Inhibitory effect on CD40, IFN-induced protein-10, and inducible nitric-oxide synthase expression
M Delgado
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Neuroprotective effect of vasoactive intestinal peptide (VIP) in a mouse model of Parkinson's disease by blocking microglial activation
M Delgado et al.
FASEB JOURNAL (2003)
Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit the production of inflammatory mediators by activated microglia
M Delgado et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2003)
Risk factors for Alzheimer's disease:: A prospective analysis from the Canadian Study of Health and Aging
J Lindsay et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2002)
Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit the MEKK1/MEK4/JNK signaling pathway in endotoxin-activated microglia
M Delgado
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
Interactions among adenosine deaminase, adenosine A(1) receptors and dopamine D-1 receptors in stably cotransfected fibroblast cells and neurons
M Torvinen et al.
NEUROSCIENCE (2002)
Control of the cell survival/death decision by cannabinoids
M Guzman et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2001)
Evidence for adenosine/dopamine receptor interactions:: Indications for heteromerization
R Franco et al.
NEUROPSYCHOPHARMACOLOGY (2000)
Dopamine D1 and adenosine A1 receptors form functionally interacting heteromeric complexes
S Ginés et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Association of coffee and caffeine intake with the risk of Parkinson disease
GW Ross et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
分享论文
